Author:
Xu Shan,Zhou Yanping,Geng Hui,Song Dandan,Tang Jing,Zhu Xianmin,Yu Di,Hu Sheng,Cui Yanfang
Publisher
Springer Science and Business Media LLC
Reference50 articles.
1. Torre, L. A. et al. Global cancer statistics, 2012. CA-cancer J. Clin. 65, 87–108 (2015).
2. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2015. CA-cancer J. Clin 65, 5–29 (2015).
3. Lemjabbar-Alaoui, H., Hassan, O. U., Yang, Y. W. & Buchanan, P. Lung cancer: Biology and treatment options. Bba-Rev. Cancer 1856, 189–210 (2015).
4. Lee, S. M. et al. First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 13, 1161–1170 (2012).
5. Zhang, C., Huang, C., Wang, J., Wang, X. & Li, K. Maintenance or Consolidation Therapy for Non–Small-Cell Lung Cancer: A Meta-Analysis Involving 5841 Subjects. Clin. Lung Cancer 16, e15–23 (2015).
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献